98-26645. National Mammography Quality Assurance Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 63, Number 193 (Tuesday, October 6, 1998)]
    [Notices]
    [Page 53680]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-26645]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    National Mammography Quality Assurance Advisory Committee; Notice 
    of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: National Mammography Quality Assurance Advisory 
    Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on November 2, 1998, 9 a.m. 
    to 6 p.m., and November 3, 1998, 8 a.m. to 5 p.m.
        Location: Hilton Hotel, Salons A and B, 620 Perry Pkwy., 
    Gaithersburg, MD.
        Contact Person: Charles A. Finder, Center for Devices and 
    Radiological Health (HFZ-240), Food and Drug Administration, 1350 
    Piccard Dr., Rockville, MD 20850, 301-594-3332, or FDA Advisory 
    Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
    Washington, DC area), code 12397. Please call the Information Line for 
    up-to-date information on this meeting.
        Agenda: On November 2, 1998, the committee will discuss the 
    compliance draft guidance entitled ``The Mammography Quality Standards 
    Act Final Regulations.'' Single copies of the draft guidance document 
    are available to the public by calling 1-800-899-0381 or 301-827-0111, 
    and requesting Fact-on-Demand number 1259, or on the Internet using the 
    World Wide Web (WWW) (http://www.fda.gov/cdrh/dmqrp.html). On November 
    3, 1998, the committee will receive updates on the issues of States as 
    certifying bodies under the Mammography Quality Standards Act (the 
    MQSA), congressional reauthorization of the MQSA, and Voluntary 
    Stereotactic Accreditation Programs.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by October 5, 
    1998. Oral presentations from the public will be scheduled between 
    approximately 9:30 a.m. and 10:30 a.m. on November 2, 1998. Time 
    allotted for each presentation may be limited. Those desiring to make 
    formal oral presentations should notify the contact person before 
    October 5, 1998, and submit a brief statement of the general nature of 
    the evidence or arguments they wish to present, the names and addresses 
    of proposed participants, and an indication of the approximate time 
    requested to make their presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: September 28, 1998.
     Michael A. Friedman,
     Deputy Commissioner for Operations.
    [FR Doc. 98-26645 Filed 10-5-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
10/06/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-26645
Pages:
53680-53680 (1 pages)
PDF File:
98-26645.pdf